| Financial Year |
March 31 2023 |
| Monetary Funds |
462,675,303.01 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
237,305,801.68 |
| Advances to Suppliers |
35,315,315.14 |
| Other Receivables |
2,880,151.27 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
518,400.00 |
| Dividend Receivable |
-- |
| Inventories |
319,164,999.27 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
181,705,858.91 |
| Total Current Assets |
1,383,047,348.53 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
120,073,548.99 |
| Investment Properties |
1,322,622.72 |
| Fixed Assetes |
1,124,063,280.63 |
| Under-construction Projects |
105,385,259.44 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
188,714,588.69 |
| R&D expenses |
-- |
| Goodwill |
50,680,711.63 |
| Long-Term Deferred and Prepaid Expenses |
7,786,819.37 |
| Deferred Income Tax Assets |
37,564,798.17 |
| Other Non-Current Assets |
57,131,853.39 |
| Sub-Total of Non-Current Assets |
1,718,599,983.50 |
| Total Assets |
3,101,647,332.03 |
| Short-Term Loans |
166,988,075.95 |
| Trading Financial liabilities |
-- |
| Notes Payable |
113,779,619.49 |
| Accounts Payable |
211,126,001.89 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
12,848,841.05 |
| Taxes Payable |
18,522,924.55 |
| Interest Payable |
-- |
| Dividend Payable |
21,609,000.00 |
| Other payables |
27,478,956.37 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
59,954,435.09 |
| Other Current Liabilities |
5,108,791.54 |
| Sub-Total of Current Liabilities |
655,520,520.95 |
| Long-term Loans |
185,087,967.53 |
| Bonds Payable |
79,807,290.28 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
27,457,258.05 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
358,609,056.62 |
| Total Liabilities |
1,014,129,577.57 |
| Paid-In Capital(Or Share Stock) |
537,246,300.00 |
| Capital Surplus |
527,898,845.46 |
| Surplus Reserve |
80,983,276.60 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
614,758,060.00 |
| Minority Stockholder's Interest |
308,404,743.06 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,779,113,011.40 |
| Owner's Equity（Stockholder's Equity） |
2,087,517,754.46 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,101,647,332.03 |
